Trial Profile
SSRIs and Self-harm in Borderline Personality Disorder.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Borderline personality disorders
- Focus Therapeutic Use
- 12 Jun 2019 Status changed from completed to discontinued.
- 07 Apr 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 21 Dec 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.